Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.
Haggag AZ, Xu J, Butcher L, Pagnussat S, Davies G, Lundqvist S, Wang W, Van Zuydam N, Nelander K, Jha A, Yu H, Boianelli A, Lindmark B, Ollerstam A, Sun X, Wang F, Pan X, Liu H, Chen W, Xu J, Wallenius K, Zhou J.
Haggag AZ, et al. Among authors: wallenius k.
Diabetes Obes Metab. 2024 Nov 4. doi: 10.1111/dom.16047. Online ahead of print.
Diabetes Obes Metab. 2024.
PMID: 39495140